MAM
ICVX

Marquette Asset Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Marquette Asset Management’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,823
Closed -$237K – 229
2022
Q4 		$237K Buy
+29,823
New +$128K 0.07% 62

Other funds holding ICVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Marquette Asset Management's ICVX Position: Q1 2023 in Review

Marquette Asset Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2023, closing a stake of 29,823 shares — an estimated $237K sold.

Marquette Asset Management first reported a position in ICVX in Q4 2022 and held it in 1 quarter. The position peaked at $237K in Q4 2022. 66 funds tracked by Wall St. Rank hold ICVX as of Q1 2023.

  • Marquette Asset Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Marquette Asset Management sold 29,823 Icosavax, Inc. Common Stock shares in Q1 2023, an estimated $237K.
  • Marquette Asset Management first reported a position in Icosavax, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Marquette Asset Management's Icosavax, Inc. Common Stock position peaked at $237K in Q4 2022.
  • 66 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2023.

Based on Marquette Asset Management's 13F filing for Q1 2023, filed 1 May 2023.